Johnson & Johnson Newsroom

'Trump To Sign Order To Encourage Domestic Drug Manufacturing' - Washington Post

Benzinga23:04 ET

Oric Pharmaceuticals Announces Clinical Trial Collaboration And Supply Agreement With Johnson & Johnson To Evaluate ORIC-114 In Combination With Subcutaneous Amivantamab For The First-Line Treatment Of NSCLC Patients With EGFR Exon 20 Insertion Mutations

Benzinga16:13 ET

Top Midday Stories: Trump Vows 100% Tariff on Foreign-Made Films; Buffett to Step Down As Berkshire CEO

MT Newswires12:19 ET

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

BenzingaMay 5 11:43 ET

Market Chatter: India Offers US Reciprocal Zero Tariffs on Steel, Auto Parts, Pharmaceutical Drugs

MT NewswiresMay 5 10:52 ET

Was Jim Cramer Right About Johnson & Johnson (JNJ)?

Yahoo FinanceMay 5 09:29 ET

Teva, Alvotech Get FDA Nod for Johnson & Johnson Biosimilar

Seeking AlphaMay 5 09:27 ET

Johnson & Johnson Announces New Data From Phase 3 ASTRO Study Evaluating TREMFYA Subcutaneous Induction Therapy In Adults With Ulcerative Colitis

BenzingaMay 5 08:13 ET

Express News | Tremfya® (Guselkumab) Positioned to Become the First and Only Il-23 Inhibitor to Offer Subcutaneous Induction in Ulcerative Colitis as Demonstrated in New Data Through 24 Weeks

ReutersMay 5 08:05 ET

Nanobiotix Says Potential Pancreatic Cancer Treatment Extends Survival in Phase 1 Study

MT NewswiresMay 5 04:09 ET

UnitedHealth's Stock Is Ailing. A Bigger Business Hasn't Helped. -- Barrons.com

Barron'sMay 4 00:05 ET

Catalyst Watch: Powell Presser, AMD Earnings, IBM Event, and Lions Gate Splits in Two

Seeking AlphaMay 2 15:00 ET

RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181

Moomoo NewsMay 2 07:31 ET · Ratings

Goldman Sachs Adjusts Price Target on Johnson & Johnson to $176 From $172, Maintains Buy Rating

MT NewswiresMay 2 07:12 ET · Ratings

SA Charts: How U.S. Manufacturing Jobs Have Declined Since the 1980s

Seeking AlphaMay 2 06:43 ET

Express News | Jnj-Backed Histosonics Is Pursuing a Sale After Fielding Takeover Bids, Seeking a Valuation of More Than $2.5Bn - FT

ReutersMay 2 00:04 ET

8 Health Care Stocks Whale Activity In Today's Session

BenzingaMay 1 13:35 ET

Johnson & Johnson (JNJ.US) has received FDA approval for a potential blockbuster therapy.

Zhitong Finance APP learned that Johnson & Johnson (JNJ.US) announced that the USA FDA has approved the market launch of its antibody therapy Imaavy (nipocalimab).

Zhitong FinanceApr 30 21:48 ET

On April 30, the top 20 trading volumes in the U.S. stock market: Super Micro Computer's preliminary Earnings Reports significantly missed expectations.

On Wednesday, Tesla, ranked first in U.S. stock trading volume, closed down 3.38% with a transaction volume of 35.226 billion USD. Data shows that as of the week ending April 27, the number of new registered Tesla electric vehicles in the domestic market was 10,300, a 51% increase from the previous week's 6,780, but down 30.5% compared to the same period last year. NVIDIA, ranked second, closed down 0.09% with a transaction volume of 23.471 billion USD. Super Micro Computer, a manufacturer of AI servers, provided a performance forecast that was far below expectations, raising concerns among investors about weak demand for AI servers, which dragged down stocks like NVIDIA. Meta ranked third.

Global Market ReportApr 30 17:23 ET

Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months?

Yahoo FinanceApr 30 14:28 ET